Results 141 to 150 of about 2,175,372 (155)

FGD5-AS1/miR-5590-3p/PINK1 induces Lenvatinib resistance in hepatocellular carcinoma

Cellular Signalling, 2023
Wenpeng Liu
exaly  

Epidermal growth factor receptor activation confers resistance to lenvatinib in thyroid cancer cells

Cancer Science, 2022
Ken-Ichi Ito
exaly  

Activation of the HGF/c-MET axis promotes lenvatinib resistance in hepatocellular carcinoma cells with high c-MET expression

Medical Oncology, 2020
Shaotao Jiang, Jieyuan Li
exaly  

Genome-Scale CRISPR screen identifies LAPTM5 driving lenvatinib resistance in hepatocellular carcinoma

Autophagy, 2023
exaly  

Top bar navigation

Frontiers in Oncology, 2022
Dawei Sun
exaly  

The action and resistance mechanisms of Lenvatinib in liver cancer

Molecular Carcinogenesis, 2023
Wei Qiu
exaly  

New insights into the mechanism of resistance to lenvatinib and strategies for lenvatinib sensitization in hepatocellular carcinoma

Drug Discovery Today
Han-Hua Dong, Zhe-Sheng Chen, Joshua S Fleishman   +2 more
exaly  

Insights into lenvatinib resistance: mechanisms, potential biomarkers, and strategies to enhance sensitivity

Medical Oncology
Jun Zheng, Hai-Tian Chen, Cui-Cui Xiao
exaly  

Targeting METTL8 with Rabdosiin overcomes lenvatinib resistance in hepatocellular carcinoma

Experimental Cell Research
Pengfei Yu, Shuning Wang
exaly  

EVA1A reverses lenvatinib resistance in hepatocellular carcinoma through regulating PI3K/AKT/p53 signaling axis

Apoptosis: an International Journal on Programmed Cell Death
Ning Li, Yuling Yang
exaly